News | April 03, 2025
Asahi Kasei Life Science begins operation
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
Divestment is part of BASF’s strategic portfolio optimization
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
Subscribe To Our Newsletter & Stay Updated
